COP vs LAB
ConocoPhillips (COP) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the COP and LAB stock pages for the full models.
Not investment advice.